Volastra Therapeutics Announces New and Expanded Partnerships with AI and Precision-Medicine Leaders to Broaden Potential of KIF18A Inhibitors Across Cancer tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
A new study has identified a set of 140 genes that may help predict enhanced disease-free survival in patients with non-small-cell lung cancer treated with a combination of immunotherapy and low-dose radiation.
D-FW biotech firm completes "first ever" AI clinical trial dallasnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dallasnews.com Daily Mail and Mail on Sunday newspapers.
Life sciences veteran’s experience leading R&D organizations and bringing more than 25 products to market will support Volastra’s growing pipeline of treatments targeting chromosomally unstable cancersNEW YORK (BUSINESS WIRE) Volastra Therapeutics, a clinical-stage cancer biotechnology company, today announced the.